Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacyclics completes phase I testing of Lu-Tex

Jan. 8, 1997

Draxis acquires Canadian rights to Mylan's paclitaxel formulation

Jan. 8, 1997

New form of DNA linked to prostate cancer

Jan. 8, 1997

Joint venture formed to develop cancer therapy

Jan. 7, 1997

NeoRx technology receives additional patent

Jan. 7, 1997

p53 proteins with altered tetramerization domains synthesized

Jan. 7, 1997

Immunex presents novel cytokine

Jan. 7, 1997

Immunex reports epithelium-derived T-cell factor polypeptides

Jan. 7, 1997

First NDA submission for NeoPharm seeks approval for two indications

Jan. 3, 1997

TxA2 antagonists modulate tumor sensitivity to platinum anticancer drugs

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...